Literature DB >> 22992873

Pretreatment PET in breast cancer: is there a role?

Sue Chua, Ashley M Groves.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22992873     DOI： 10.1007/s00259-012-2216-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  23 in total

1.  Positron emission tomography and neoadjuvant therapy of breast cancer.

Authors:  Alexandre Cochet; Daniele Generali; Stephen B Fox; Francesco Ferrozzi; Rodney J Hicks
Journal:  J Natl Cancer Inst Monogr       Date:  2011

Review 2.  The role of antiangiogenetic agents in the treatment of breast cancer.

Authors:  M A Bareschino; C Schettino; G Colantuoni; E Rossi; A Rossi; P Maione; F Ciardiello; C Gridelli
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

3.  Positron emission tomography imaging of CD105 expression during tumor angiogenesis.

Authors:  Hao Hong; Yunan Yang; Yin Zhang; Jonathan W Engle; Todd E Barnhart; Robert J Nickles; Bryan R Leigh; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-04       Impact factor: 9.236

4.  Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.

Authors:  David A Mankoff; Lisa K Dunnwald; Julie R Gralow; Georgiana K Ellis; Aaron Charlop; Thomas J Lawton; Erin K Schubert; Jeffrey Tseng; Robert B Livingston
Journal:  J Nucl Med       Date:  2002-04       Impact factor: 10.057

5.  Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.

Authors:  N Avril; C A Rosé; M Schelling; J Dose; W Kuhn; S Bense; W Weber; S Ziegler; H Graeff; M Schwaiger
Journal:  J Clin Oncol       Date:  2000-10-15       Impact factor: 44.544

6.  Preoperative PET/CT in early-stage breast cancer.

Authors:  M Bernsdorf; A K Berthelsen; V T Wielenga; N Kroman; D Teilum; T Binderup; U B Tange; M Andersson; A Kjær; A Loft; J Graff
Journal:  Ann Oncol       Date:  2012-02-21       Impact factor: 32.976

7.  Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.

Authors:  Sandip Basu; Wengen Chen; Julia Tchou; Ayse Mavi; Tevfik Cermik; Brian Czerniecki; Mitchell Schnall; Abass Alavi
Journal:  Cancer       Date:  2008-03-01       Impact factor: 6.860

8.  Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients.

Authors:  Till A Heusner; Sherko Kuemmel; Steffen Hahn; Angela Koeninger; Friedrich Otterbach; Monia E Hamami; Klaus R Kimmig; Michael Forsting; Andreas Bockisch; Gerald Antoch; Alexander Stahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-05       Impact factor: 9.236

9.  Impact of combined (18)F-FDG PET/CT in head and neck tumours.

Authors:  R Syed; J B Bomanji; N Nagabhushan; S Hughes; I Kayani; A Groves; S Gacinovic; N Hydes; D Visvikis; C Copland; P J Ell
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640

10.  Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CT.

Authors:  Ashley M Groves; Gordon C Wishart; Manu Shastry; Penelope Moyle; Sharon Iddles; Peter Britton; Mathew Gaskarth; Ruth M Warren; Peter J Ell; Kenneth A Miles
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09-26       Impact factor: 9.236
View more
  2 in total

1.  Staging the axilla in breast cancer patients with ¹⁸F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?

Authors:  Dimitri Bellevre; Cécile Blanc Fournier; Odile Switsers; Audrey Emmanuelle Dugué; Christelle Levy; Djelila Allouache; Cédric Desmonts; Hubert Crouet; Jean-Marc Guilloit; Jean-Michel Grellard; Nicolas Aide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

2.  PET Probe-Guided Surgery in Patients with Breast Cancer: Proposal for a Methodological Approach.

Authors:  Paolo Orsaria; Agostino Chiaravalloti; Alessandro Fiorentini; Chiara Pistolese; Gianluca Vanni; Alessandra Vittoria Granai; Dimitrios Varvaras; Roberta Danieli; Orazio Schillaci; Giuseppe Petrella; Oreste Claudio Buonomo
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.